Progress Against Objectives - December 2017
Status (as at December 2017)
Develop the North Terrace Health Precinct as the cornerstone of South Australia’s health economy
The Adelaide BioMed City is one of the largest life sciences precincts in the southern hemisphere. The new Royal Adelaide Hospital opened in September 2017. The South Australian Health and Medical Research Institute (SAHMRI) is operational next door, Adelaide University’s Health and Medical Sciences Building is now operating and the University of South Australia’s Health Innovation Building is due to open in 2018.
The proposed SAHMRI 2 building will include the only Proton Therapy Unit in the Southern Hemisphere and will expand SAHMRI’s capacity to conduct ground-breaking research, and dramatically increase Australian patients’ access to the best cancer care.
Increase South Australia’s share of total National Health and Medical Research Council (NHMRC) funding by 20% from it’s 2013 baseline (currently 6.5%)
South Australia’s share of research funding has reduced and was 5.9% of total NHRMC funding in 2016. Final data for this objective is expected to be made available by the end of March 2018.
The state government is collaborating with universities in South Australia and SAHMRI, to explore the reasons behind the reduction in the State's share of funding. It will then assess the most appropriate investment options to reverse this trend.
Attract $150m in foreign investment to SA in the life science sector.
Over $150m has been invested in the SA life science sector between the announcement of the ten economic priorities and October 2017.
Nine companies (AACHES, Micro-X, Somark Innovations, Trajan Scientific, Hydrix, Pfizer, GEN1 Biotechnology, I’rom and Firma Group), are expected to generate an estimated $1.23 billion of economic benefit to South Australia.
Support the continued development of the local clinical trials environment, increasing new trial notifications from 66 to 80 by 2017.
South Australia has a very supportive environment for clinical trials with: a 43.5% cashback for clinical trials, analytics and study drug manufacture; facilities for preclinical and Phase 1, 2 and 3 trials; full range of services: clinical, data, bioanalytical, and study drug manufacture; no investigational new drug (IND) requirement; and ethics approval in an average of six weeks, saving six to nine months.
The commonwealth government advises that the reporting methodology on the number of clinical trials has changed, and that the state government is currently unable to access data for new clinical trial notifications.
Establish a leading tele–health industry encompassing tele–health services, remote monitoring and mobile monitoring
As at November 2017, three international digital health companies that use artificial intelligence and machine learning technologies to deliver health services, have been attracted to South Australia. They are Firma Group, Medi-Map and Symmetric.
Develop South Australia as the health and biomedical cluster for national and international companies, and attract at least three significant companies to the State
As at October 2017, the state government has attracted six companies to Adelaide, creating jobs through the supply chain and injecting millions of dollars into the South Australian economy. The companies attracted are MedxBio (GEN1), Somark, Micro-X, Hydrix, Trajan and Pfizer.
Develop an international reputation for our high levels of older citizen participation in economic and community life.
The inaugural Ageing Well Revolution International Conference was held at the Adelaide Convention Centre in November 2017. The conference highlighted the leading transformational global trends in the ageing well sector and brought together international experts to explore the business and social innovation opportunities from the world’s ageing demographic.
The state government’s Policy Framework for the Development of an Ageing Well Industry was launched in August 2017 setting the basis for cross-government and industry collaboration to support business growth and develop innovative solutions critical for ageing well now and in the future. The Policy Framework identifies a number of sectors that are poised to become particular areas of opportunity for South Australia, recognising the strong role of older people as consumers, market drivers and do-designers in shaping the products and services of the future.
Create new products and services for the state and the world, establishing expertise in active ageing
An early action of the Policy Framework for the Development of an Ageing Well Industry was the Innovation in Social Housing 90 Day Project. This project engaged older Housing SA tenants in a co-design process with builders, architects, planners, developers and aged care providers to explore innovative housing models for South Australia that meet the changing and diverse needs of older people and develop a set of design principles for age friendly homes and neighbourhoods.
The outcomes of this project highlight the future economic opportunities generated by an ageing population in relation to housing and neighbourhood design
Secure significant health and biomedical conferences in South Australia to promote business–to–business or business–to–research partnering
Notable health and biomedical conferences held in South Australia since May 2016 include:
Create 3500 jobs through the rollout of the National Disability Insurance Scheme.
The NDIS transition Bilateral Agreement, estimated approximately 15,300 additional participants will join the scheme by completion of the roll out in 2019.
The 2016 Market Position Statement for South Australia estimates that this additional demand will grow the SA market from $760m as at June 2016 to $1.5bn in June 2019 and the workforce required to service demand will grow from 5,600–6,900 FTEs (June 2016) to 10,200 - 12,600 FTEs by 2019.
As at 30 June 2017, 94% of the cumulative bilateral estimate has been met. Hence, it follows that growth in the scheme will remain on track with the Bilateral Agreement as will the growth in required workforce. This growth is expected to accelerate in the second half of 2017-18 and in 2018-19.
Increase international medical equipment and devices exports from $151 million in 2013/14.
In 2016-17 medical devices exports were $239 million.